Heart failure & cardiomyopathiesRandomised controlled trial
Home-based body water monitoring and management system for heart failure patients using bioelectrical impedance analysis
- multicentre, open-label, randomized controlled trial
Authors' conclusion
Home-based BIA monitoring with pre-emptive management is feasible, acceptable, and safe for patients with HF.
Study context
- Population
- Heart failure (HF) patients receiving loop diureticsThirty-nine patients included in the final analysis after exclusion of one patient lost to follow-up in the control group
- Participants
- 40 patients
- Comparison
- home bioelectrical impedance analysis (BIA) group vs standard care
Primary result
As reported in the abstract
Changes in NT-proBNP or oedema index · during follow-up
- No significant differences between groups
Further findings
Worsening NYHA class · less frequently in the home BIA group
P = 0.095
Baseline NT-proBNP · higher in control group
P = 0.013
| Outcome | home BIA group | control group | P value |
|---|---|---|---|
| Baseline age · control group older | 57.2 ± 13.5 | 70.4 ± 8.3 | P = 0.003 |
HF hospitalizations or deaths
- No HF hospitalizations or deaths occurred
Completion rate and adherence to BIA measurements (home BIA group)
- completion rate
- 100.0%
- adherence to BIA measurements
- 82.5%
Usability and acceptability (5-point Likert scale)
- Usability
- 4.21 ± 0.59
- Acceptability
- 3.90 ± 0.53
Correlation of changes with changes in NT-proBNP
- Changes in oedema index
- r = 0.544; P = .002
- Changes in body weight
- r = 0.237; P = .147
Safety
Acute kidney injury
- Acute kidney injury
- one patient (5.0%)
- No discontinuations due to adverse events
Original publication
Home-based body water monitoring and management system for heart failure patients using bioelectrical impedance analysis. ESC Heart Fail. Published 16 April 2026. doi:10.1093/eschf/xvag106
Summarised from the published abstract; every number is checked against it